The future of IgE-mediated allergy research and treatments
In her laboratory, Cecilia Berin, Ph.D., the Bunning Professor of Food Allergy Research, studies the immune basis of allergy and tolerance to foods.
Mar 30, 2023
0
2
In her laboratory, Cecilia Berin, Ph.D., the Bunning Professor of Food Allergy Research, studies the immune basis of allergy and tolerance to foods.
Mar 30, 2023
0
2
Memory B cells play a critical role to provide long-term immunity after a vaccination or infection. In a study published in the journal Immunity, researchers describe a distinct and novel subset of memory B cells that predict ...
Mar 22, 2023
0
63
For patients with cancer, age, cancer type, and comorbidity are associated with differential COVID-19 vaccine uptake rates, according to a study published online March 15 in Cancer.
Mar 16, 2023
0
4
A new approach that delivers a "one-two punch" to help T cells attack solid tumors is the focus of a preclinical study by researchers from the Perelman School of Medicine at the University of Pennsylvania. The findings, published ...
Mar 15, 2023
0
39
The search for new therapies to treat a rare type of non-Hodgkins lymphoma has had an unexpected success—identifying a potential molecular target to treat other related forms of lymphoma as well.
Mar 14, 2023
0
2
Researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health have identified a strong association between the product of a gene expressed in most cancers, including ...
Mar 13, 2023
0
61
A recently published study from Aarhus University may mean a textbook chapter on the immune system will have to be rewritten.
Mar 10, 2023
0
436
A group of University of Pittsburgh researchers has given new meaning to "knowing your ABCs." In a new study, published in the Journal of Experimental Medicine, the team showed that a type of immune cell called age-associated ...
Mar 2, 2023
0
29
For almost 140 years, the origin and behavior of an enigmatic cell type inside lymph nodes, called a tingible body macrophage, has remained a mystery. Now, for the first time, scientists at the Garvan Institute of Medical ...
Mar 2, 2023
0
21
Blood cancer patients, especially when they relapse, have a poor prognosis, and generally do not survive very long. The last five years have seen success in treating these patients with Chimeric Antigen Receptor (CAR) T-cells—a ...
Feb 24, 2023
0
50